 Harmony Biosciences Holdings Inc NASDAQ: HRMY has entered into a 330 million financing collaboration with The Blackstone Group Inc NYSE: BX. The financing deal includes up to 300 million in debt capital, consisting of a 200 million senior secured term loan facility and a 100 million senior secured delayed draw term loan facility available to be drawn within 12 months of closing. 